rosiglitazone has been researched along with Diabetes Mellitus, Lipoatrophic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donohoe, M; Ellard, S; Hattersley, AT; Owen, KR | 1 |
| Grinspoon, S; Hadigan, C; Kamin, D; Lazar, MA; Lehrke, M; Mazza, S | 1 |
| Genschel, J; Heck, K; Lüdtke, A; Mehnert, H; Schmidt, HH; Spuler, S; Worman, HJ | 1 |
| Arioglu, E; Chao, L; Gavrilova, O; Marcus-Samuels, B; Mason, MM; Moitra, J; Reitman, ML; Vinson, C | 1 |
1 trial(s) available for rosiglitazone and Diabetes Mellitus, Lipoatrophic
| Article | Year |
|---|---|
Resistin levels in human immunodeficiency virus-infected patients with lipoatrophy decrease in response to rosiglitazone.
Topics: Adult; CD4 Lymphocyte Count; Diabetes Mellitus, Lipoatrophic; Female; HIV Infections; Hormones, Ectopic; Humans; Hypoglycemic Agents; Male; Middle Aged; PPAR gamma; Resistin; Rosiglitazone; Thiazolidinediones | 2005 |
3 other study(ies) available for rosiglitazone and Diabetes Mellitus, Lipoatrophic
| Article | Year |
|---|---|
Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Lipoatrophic; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Lamin Type A; Leptin; Mutation; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Skinfold Thickness; Thiazolidinediones; Transcription Factors | 2003 |
Long-term treatment experience in a subject with Dunnigan-type familial partial lipodystrophy: efficacy of rosiglitazone.
Topics: Aged; Diabetes Mellitus, Lipoatrophic; Fatal Outcome; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; PPAR gamma; Rosiglitazone; Thiazolidinediones; Triglycerides | 2005 |
Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones.
Topics: Adipose Tissue; Animals; Blood Glucose; Chromans; Diabetes Mellitus, Lipoatrophic; Disease Models, Animal; Female; Hypoglycemic Agents; Insulin; Ligands; Liver; Mice; Mice, Inbred C57BL; Mice, Transgenic; Receptors, Cytoplasmic and Nuclear; Respiratory Function Tests; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Triglycerides; Troglitazone | 2000 |